SCHEMBL25914852

SCHEMBL25914852

CCNc1ncc(-c2ccc3cc(Oc4ccnc(Br)c4)cnc3n2)c(=O)n1C

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CSF1R P07333 6/20 0.40
▸ FLT3 P36888 4/20 0.40
▸ PDGFRB P09619 2/20 0.40
▸ PDGFRA P16234 2/20 0.40
▸ LCK P06239 2/20 0.40
▸ KIT P10721 1/20 0.40
▸ CYP2C9 P11712 1/20 0.40
▸ PTK6 Q13882 1/20 0.40
▸ BRAF P15056 6/20 0.34
▸ RAF1 P04049 5/20 0.34
▸ EGFR P00533 1/20 0.32
▸ FGFR1 P11362 1/20 0.32
▸ AURKA O14965 1/20 0.30
▸ RPS6KA5 O75582 1/20 0.30
▸ MET P08581 1/20 0.30
▸ PIM1 P11309 1/20 0.30
▸ HGF P14210 1/20 0.30
▸ RPS6KB1 P23443 1/20 0.30
▸ KDR P35968 1/20 0.30
▸ MAPK9 P45984 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25914470 0.90 CSF1R (0.42) CSF1RFLT3PDGFRBPDGFRALCK
SCHEMBL25319458 0.88 CSF1R (0.52) CSF1RFLT3PDGFRBPDGFRALCK
SCHEMBL25910929 0.85 BRAF (0.40) CSF1RFLT3PDGFRBPDGFRALCK
SCHEMBL25910915 0.85 CSF1R (0.59) CSF1RFLT3PDGFRBPDGFRALCK
SCHEMBL25910931 0.84 GCK (0.44) CSF1RFLT3PDGFRBPDGFRALCK
SCHEMBL25910939 0.81 CSF1R (0.38) CSF1RFLT3PDGFRBPDGFRALCK
SCHEMBL25910943 0.81 CSF1R (0.38) CSF1RFLT3PDGFRBPDGFRALCK
SCHEMBL25914665 0.79 CSF1R (0.39) CSF1RFLT3PDGFRBPDGFRALCK
SCHEMBL25914850 0.78 EGFR (0.35) CSF1RFLT3PDGFRBPDGFRALCK
SCHEMBL25910178 0.78 CSF1R (0.52) CSF1RFLT3PDGFRBPDGFRALCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023125812-A1 SUBSTITUTED PYRIMIDONE DERIVATIVE, AND PHARMACEUTICAL COMPOSITION AND MEDICAL USE THEREOF 上海海雁医药科技有限公司 2023-07-06 — — WO disclosed
Send feedback